Skip to main content
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1986;64(2):279–281.

A simple urine spot test for monitoring dapsone self-administration in leprosy treatment

Han Huikeshoven
PMCID: PMC2490937  PMID: 3488843

Abstract

A simple urine spot test for monitoring patient compliance to dapsone self-administration in leprosy therapy was recommended by WHO but later abandoned. The present article describes some important improvements to the test, which is characterized by its validity and straightforwardness.

Full text

PDF
279

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Colston M. J., Ellard G. A., Gammon P. T. Drugs for combined therapy: experimental studies on the antileprosy activity of ethionamide and prothionamide, and a general review. Lepr Rev. 1978 Jun;49(2):115–126. doi: 10.5935/0305-7518.19780014. [DOI] [PubMed] [Google Scholar]
  2. Ellard G. A., Gammon P. T., Helmy H. S., Rees R. J. Urine tests to monitor the self-administration of dapsone by leprosy patients. Am J Trop Med Hyg. 1974 May;23(3):464–470. doi: 10.4269/ajtmh.1974.23.464. [DOI] [PubMed] [Google Scholar]
  3. de MELLO P. [Rapid method for the detection of sulfonamides in urine]. Rev Bras Leprol. 1961 Jun;29:79–82. [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES